Results: IL-27-treated PHA-stimulated T cells (27-T) and IL-27-induced DC (27-DC) resisted HIV infection by 70% and >90%, respectively, without significant change in the expression of CD4, CCR5 or CXCR4. The gene discussed is IL27; the disease is HIV infectious disease.